MAPT and Alzheimer disease: AD typically manifests with a gradual onset and early symptoms primarily involving memory loss, which is attributed to neurotoxicity resulting from abnormal deposits of beta-amyloid in the brain and excessive phosphorylation of tau proteins (2).